“Health care products have become popular. Elements such as deep-sea fish oil, collagen, and spirulina have all become popular one after another, and plant extracts are indeed a rare ‘all-in-one’ type.” A marketing manager at a drugstore in Guangzhou told this newspaper Reporter, because we focus on plant-based brands, they feel natural and have few side effects, and many plants have indeed been proven to have certain effects on the prevention and health care of various diseases. Therefore, the market feedback is very good, and sales are increasing year by year, with middle-aged and elderly people being the main ones. Consumer groups.
Ginkgo leaf extract, bilberry extract, ginseng extract… “plant extracts” that have gone abroad and become popular all over the world have recently adopted international business standards, and listed companies participating in the formulation may benefit, and sales will also have more confidence. “. Statistics show that in the first quarter of 2013. the export value of plant extracts reached US$330 million, accounting for 47% of the export value of traditional Chinese medicine products. The United States has been ranked first in my country’s plant extract exports for many years.
Under the influence of new medical models, functional or active plant extract products are becoming more and more popular. At present, the plant extract industry is developing faster and faster, surpassing the growth rate of the pharmaceutical market and becoming an independent emerging industry. With the rise of the plant extract market worldwide, China’s plant extract industry will surely become a new strategic pillar industry for national economic and social development.
Plant extracts are the main force in my country’s exports of traditional Chinese medicine products, accounting for more than 40% of the total exports of traditional Chinese medicine products. Although the plant extract industry is an emerging industry, it has developed rapidly in the past decade. Statistics from the “2013-2017 China Plant Extract Industry Production, Marketing Demand and Investment Forecast Analysis Report” show that my country’s plant extract exports reached US$1.13 billion in 2011. a year-on-year increase of 47%, and the compound growth rate from 2002 to 2011 reached 21.91% . Plant extracts became the first commodity category with exports of traditional Chinese medicine exceeding US$1 billion.
Plant extracts are rising, favored by middle-aged and elderly people
It is understood that the plant extract industry is a rapidly developing sunrise industry. In the field of Chinese herbal medicine exports in China, plant extracts have rapidly become popular in recent years, and the export growth rate is much higher than that of traditional Chinese herbal medicines. All of this is in line with more and more countries. Started to favor nutritional and health products. Taking the United States as an example, in the traditional Chinese medicine trade between China and the United States, the main part is my country’s export of extracts to the United States. my country’s largest export of plant extract products to the United States is licorice extract, including licorice extract, glycyrrhizinate and other licorice products. The U.S. consumer market for nutraceuticals is huge, and this market is growing at an annual rate of 20%. However, due to factors such as farmers’ planting habits and production costs, the U.S.’s medicinal plant production can only meet 25% of its production needs, and the rest All APIs are imported.
After China’s plant extracts enter the international market, some are provided locally as botanical medicines or dietary supplements, and some may be processed into “foreign traditional Chinese medicine” with higher added value and sold back home. “Plant extract health products like Ginkgo biloba are gradually becoming popular at home and abroad. Germany is developing rapidly in this area. Some companies process a total of 800 tons of ginkgo leaf raw materials throughout the year.” An industry observer express.
The reporter visited Guangzhou pharmacies and browsed Taobao online stores and found that various Chinese and Western “TCM health products” are very popular, especially aloe vera, ginkgo, bilberry, grape seed, ginseng, rose hip, and various plant extract compounds. The health products are relatively hot-selling, and most of them are expensive, with the mainstream price ranging from 100 to 600 yuan per bottle. “Health care products have become popular. Elements such as deep-sea fish oil, collagen, and spirulina have all become popular one after another, and plant extracts are indeed a rare ‘all-in-one’ type.” A marketing manager at a drugstore in Guangzhou told this newspaper Reporter, because we focus on plant-based brands, they feel natural and have few side effects, and many plants have indeed been proven to have certain effects on the prevention and health care of various diseases. Therefore, the market feedback is very good, and sales are increasing year by year, with middle-aged and elderly people being the main ones. Consumer groups.
However, industry insiders also pointed out that in the emerging field of plant extract health products, Chinese and foreign companies are fighting fiercely, and it can be said that they are fighting hand-to-hand, and the advantages of China and foreign countries are also very different: “Many foreign giants have considerable advantages in technology and patents. Because Chinese herbal medicine products are still relatively sensitive, foreign companies can often take the lead in terms of extraction and separation processes, product action mechanisms, and safety evaluations. This happens to be the main disadvantage of domestic pharmaceutical companies; but our country’s Chinese medicine companies have the advantage of “geographical convenience” , Unfortunately, it is still quite difficult for traditional Chinese medicine companies to ‘break through’ abroad.” He said.
Listed companies will benefit from the implementation of plant extract standards
According to the China Chamber of Commerce for Import and Export of Medicines and Health Products, the first batch of international business standards for plant extracts have been recently released and will be officially implemented on October 1. The reporter learned that Rheinland Biotechnology is one of the participants in the formulation of this plant extraction standard, and many listed companies may benefit from the formulation of this new standard.
The Chamber of Commerce’s Plant Extract Standards Committee previously revealed: “The formulation of this standard will create a good growth environment for the plant extract industry, especially for high-quality companies, which will gain ‘price say’ and ‘pricing power’, making this type of Companies are more proactive in the trade of plant extracts.”
Among the seven international business standards for plant extracts released this time, the international business standard for ginkgo leaf extract is currently the highest international standard, even higher than the similar plant extract standards in the EU and the United States. This will also provide a good foundation for my country’s plant extracts. Going abroad adds a lot of weight.
The reporter noticed that listed companies related to plant extracts include Jiaotong University Only, Chenguang Biotech, Conba, Rhine Biotechnology, Tasly, Yunnan Baiyao, Baiyunshan, etc. “These listed companies are all strong and high-quality companies with relatively rich product lines. Some of them also have exclusive varieties of traditional Chinese medicine that have entered the essential medicine catalog, so they should be strong in research and development and other aspects; some have traditional Chinese medicine. It is a plantation and processing base and is quite confident in the source of raw materials.” A pharmaceutical industry analyst said that if investors are interested in the content of plant extracts, they can choose relevant stocks to pay attention to.